How to handle oligometastatic disease in nonsmall cell lung cancer
Patients with nonsmall cell lung cancer and limited metastatic disease have been defined as oligometastatic if local ablative therapy of all lesions is amenable. Evidence from different clinical retrospective series suggests that this subgroup harbours better prognosis than other stage IV patients....
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
January 13, 2021
|
| In: |
European respiratory review
Year: 2021, Volume: 30, Issue: 159, Pages: 1-12 |
| ISSN: | 1600-0617 |
| DOI: | 10.1183/16000617.0234-2020 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1183/16000617.0234-2020
|
| Author Notes: | Florian Eichhorn, Hauke Winter |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1759075167 | ||
| 003 | DE-627 | ||
| 005 | 20220819215703.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210527s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/16000617.0234-2020 |2 doi | |
| 035 | |a (DE-627)1759075167 | ||
| 035 | |a (DE-599)KXP1759075167 | ||
| 035 | |a (OCoLC)1341414792 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Eichhorn, Florian |d 1984- |e VerfasserIn |0 (DE-588)143005952 |0 (DE-627)641429045 |0 (DE-576)334573483 |4 aut | |
| 245 | 1 | 0 | |a How to handle oligometastatic disease in nonsmall cell lung cancer |c Florian Eichhorn, Hauke Winter |
| 264 | 1 | |c January 13, 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Patients with nonsmall cell lung cancer and limited metastatic disease have been defined as oligometastatic if local ablative therapy of all lesions is amenable. Evidence from different clinical retrospective series suggests that this subgroup harbours better prognosis than other stage IV patients. However, most reports have included patients with inconsistent numbers of metastases in different locations treated by a variety of invasive and noninvasive therapies. As long as further results from randomised clinical trials are awaited, treatment decision follows an interdisciplinary debate in each individual case. Surgery and radiotherapy should capture a dominant role in the treatment course offering the option of a curative-intended local therapy in combination with a systemic therapy based on an interdisciplinary decision. This review summarises the current treatment standard in oligometastatic lung cancer with focus on an ablative therapy for both lung primary and distant metastases in prognostically favourable locations. | ||
| 700 | 1 | |a Winter, Hauke |e VerfasserIn |0 (DE-588)1162076038 |0 (DE-627)1025509773 |0 (DE-576)176791531 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European respiratory review |d Sheffield : Soc., 2005 |g 30(2021), 159, Artikel-ID 200234, Seite 1-12 |h Online-Ressource |w (DE-627)500021430 |w (DE-600)2202947-3 |w (DE-576)281286477 |x 1600-0617 |7 nnas |a How to handle oligometastatic disease in nonsmall cell lung cancer |
| 773 | 1 | 8 | |g volume:30 |g year:2021 |g number:159 |g elocationid:200234 |g pages:1-12 |g extent:12 |a How to handle oligometastatic disease in nonsmall cell lung cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1183/16000617.0234-2020 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210527 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1162076038 |a Winter, Hauke |m 1162076038:Winter, Hauke |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PW1162076038 |e 950000PW1162076038 |e 950900PW1162076038 |e 50000PW1162076038 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 2 |y j | ||
| 998 | |g 143005952 |a Eichhorn, Florian |m 143005952:Eichhorn, Florian |d 910000 |d 950000 |d 950900 |e 910000PE143005952 |e 950000PE143005952 |e 950900PE143005952 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 1 |x j | ||
| 999 | |a KXP-PPN1759075167 |e 393185017X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Florian Eichhorn, Hauke Winter"]},"relHost":[{"id":{"eki":["500021430"],"issn":["1600-0617"],"zdb":["2202947-3"]},"recId":"500021430","title":[{"title_sort":"European respiratory review","title":"European respiratory review"}],"note":["Gesehen am 31.10.24"],"part":{"issue":"159","extent":"12","year":"2021","volume":"30","pages":"1-12","text":"30(2021), 159, Artikel-ID 200234, Seite 1-12"},"language":["eng"],"disp":"How to handle oligometastatic disease in nonsmall cell lung cancerEuropean respiratory review","type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Soc.","publisherPlace":"Sheffield","dateIssuedKey":"2005","dateIssuedDisp":"2005-"}],"corporate":[{"role":"isb","display":"European Respiratory Society"}],"pubHistory":["Nachgewiesen 14.2005 - ; auch mit durchgehender Nr.-Zählung"],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["European Respiratory Society"]}}],"person":[{"given":"Florian","display":"Eichhorn, Florian","family":"Eichhorn","role":"aut"},{"given":"Hauke","display":"Winter, Hauke","role":"aut","family":"Winter"}],"physDesc":[{"extent":"12 S."}],"language":["eng"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"January 13, 2021"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1759075167","id":{"doi":["10.1183/16000617.0234-2020"],"eki":["1759075167"]},"title":[{"title_sort":"How to handle oligometastatic disease in nonsmall cell lung cancer","title":"How to handle oligometastatic disease in nonsmall cell lung cancer"}]} | ||
| SRT | |a EICHHORNFLHOWTOHANDL1320 | ||